Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03813147
Brief Title: Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome

First Submitted : January 21, 2019
First Submitted that Met QC Criteria : January 21, 2019
First Posted : January 23, 2019

Last Update Submitted that Met QC Criteria : October 14, 2019
Last Update Posted : October 15, 2019